Abstract Pentavalent antimony compounds are expensive, toxic and drug resistance is prevalent, whereas the plant extract derivatives are safe. In the present study, the effect of methanolic and aqueous extracts of Eucalyptus camaldulensis on the promastigotes of Leishmania major was evaluated. The methanolic and aqueous extracts of E. camaldulensis leaves were prepared. The compounds were dried and powdered. Serial dilutions of the extracts and control drugs in phosphate buffer solution were prepared. The stationary phase promastigotes of L. major were incubated to the methanolic and aqueous extractions in vitro. Tartar emetic was used as the positive control drug. After 72 h of incubation the activity of the extracts was measured, using MTT method. The IC 50 values (50 % inhibitory concentration) were 586.2 ± 47.6 and 1,108.6 ± 51.9 lg/ml for methanolic and aqueous extracts, respectively, whereas it was 32.5 ± 6.8 lg/ml for tartar emetic. The results indicated that the methanolic extract was more effective than aqueous extract, although there was no significant difference. The extracts were less effective as compared to the control drug. Further investigation is required to evaluate these extracts on clinical stage in macrophage-amastigote model.
Introduction
Leishmaniasis is a parasitic protozoan disease caused by different species of the genus Leishmania which consists of three classical forms of disease, including cutaneous, mococutaneous and visceral leishmaniasis (Sharma et al. 2009 ). Cutaneous leishmaniasis (CL) is a disease affecting 98 countries and territories worldwide and 90 % of CL cases occur in Afghanistan, Algeria, Brazil, Iran, Peru, Saudi Arabia and Syria (Desjeux 2004; World Health Organization 2010) .
For treatment of leishmaniasis, various drugs and therapies are used, although pentavalent antimony compounds such as meglumine antimoniate (Glucantime) and sodium stibogluconate (Pentostam) are the first choice treatments. However, there is limitation for their use due to adverse side effects, cost and development of resistance. Medicinal plants provide a valuable source of new chemotherapeutic agents for treatment of leishmanial parasites (Verma and Singh 2008) . Reports on the use of anti-parasitic effect, especially leishmaniicidal activity of plant extracts or plant-derived compounds have been well documented in endemic countries (Adraiane et al. 2009; Babaee et al. 2007; Doroodgar et al. 2008; Mirzaie et al. 2007; Monzote Fidalgo et al. 2004) . For example, Eucalyptus, Myrtus, Ferula, Aretmisia, Peganum harmala, Garlic and Urtica extracts have been used in various studies against cutaneous leishmaniasis (Babaee Khou et al. 2007; Doroodgar et al. 2008; Mirzaie et al. 2007) .
Eucalyptus plants are from the family of Myrtaceae with different species. This plant contain essential oil, 60-90 % of eucalyptol (1,8-cineole) and another major monoterpenoid (Batish et al. 2008; Juergens et al. 1998 ). Extracts and oil that made from different parts of plants such as leaves and fruits have been used in several in vivo and in vitro studies against viruses (Newall et al. 1996) , bacteria (Ayepola and Adeniyi 2008) , against plasmodium species (Su et al. 2008 ) And more recently on the promastigote of Leishmania amozonensis parasites (Adraiane et al. 2009 ).
In the present study we used the methanolic and aqueous leave extracts of Eucalyptus camaldulensis to assess the leishmanicidal activity against L. major promastigotes in comparison to a trivalent antimony compound (tartar emetic).
Materials and methods

Parasite culture
Promastigotes of Leishmania major (MRHO/SU/59/P) parasite were cultured in RPMI-1640, supplemented with 15 % heat-inactivated fetal calf serum containing 100 Iu penicillin and 100 lg/ml streptomycin. This stage of the parasite in stationary phase was used as the source of the parasite in this study (Roberts and Rainey 1993; Sereno et al. 1998 ).
Plant extracts
Eucalyptus camaldulensis leaves were collected from the city of Kerman, Kerman province, south-east Iran and kindly authentitized by Dr. Mirtajadini at Department of Botany, Shahid Bahonar University, Kerman, Iran.
The leaves after drying were milled and after through sieve, were extracted with methanol 80 % and water separately by percolation method. Extraction was continued for 72 h and extract was filtered every day and fresh solvent was added to plant mark. All the filtrates were mixed and concentrated under vacuum by a rotary evaporator. Final drying was performed in oven at a temperature less than 40°C. Dried extracts were kept at -20°C until experimentation.
Potassium antimonyl tartrate (tartar emetic), trivalent antimony [Sb (III)], was supplied from Sigma (Sigma Chemical Co., St. Louis, Mo, USA) which was used as positive control drug.
2.5 mg of tartar emetic (Sb III) and the extract weighted and were solved in 1 ml of PBS (pH 7.2) and passed thorough filter (0.22 lm pore size). Serial dilutions of control drug and plant extracts (25-25,000 lg/ml) were prepared according to the method performed by Sereno et al. (2000) . Among various concentration for each extract and control drug two concentrations were used to calculate the IC 50 values. Concentrations of 25, 50, 312.5, 625 and 1,250 were used for positive control, methanolic and aquatic extracts, respectively (Fig. 1) .
Promastigote assay MTT assay was used for evaluation of the effects of control drug and extracts on the promastigotes of L. major. MTT assay is a quantitative spectrophotometric method, for assessing the growth and viability of cells by measuring mitochondrial dehydrogenase activity in living cells (Mosmann 1983) . This viability test is widely used to determine cell growth (cell survival) and for evaluation of the effect of drugs (Williams et al. 2003) . 100 ll of medium containing L. major promastigotes at the end of logarithmic growth phase were added into each well of 96 well plate and then 10 ll various concentrations of control drug and extracts were added to each well and the plates were incubated at 25 ± 1°C for 72 h. Then 10 ll of MTT solution (5 mg/ml) was added to each well and the blank well containing only 100 ll of medium alone and 10 ll of MTT solution. The plates were incubated at 25 ± 1°C for 3-4 h (Mirzaie et al. 2007 ). Finally the reaction was stopped by acidified isopropanol and optical density (OD) was measured at 490 nm (Berg et al. 1994; Sacks and Perkins 1984) . All experiments were repeated as triplicates. 
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PC ME AE Fig. 1 Comparison of optical density (OD) between positive control (PC), methanolic extract (ME), and aquatic extract (AE) on the susceptibility of Leishmania major promastigotes by colorimetric assay
Data analysis
The results of each experiment was analyzed by the method described by Huber and Koella (1993) . For calculation of the IC 50 values, we used the following mathematical formula:
Briefly, Huber and Koella proposed finding two concentrations, X1 and X2, such that the parasite density, Y1, at concentration X1 (and all lower concentrations) was more than half of the density found in the control, Y0, and that the parasite density, Y2, at concentration X2 (and all higher concentrations) was less than half of Y0. The IC 50 was then found by linear extrapolation between X1 and X2.
Statistical analysis
The univariate analysis of variance (Univariate ANOVA) and the Student's t test, at P values of \0.05 significance, were used to compare the antileishmanial activity of the methanolic and aqueous extracts of Eucalyptus as compared to that of potassium antimonyl tartrate.
Results
Antileishmanial assays
Effect of extracts and control drug on promastigote was assessed by MTT assay. Both methanolic and aqueous extracts of Eucalyptus and potassium antimonyl tartrate inhibited the growth of promastigote forms of L. major in vitro after 72 h. of incubation, and had a 50 % inhibitory concentration (IC 50 ) of 1,108.6 ± 51.9 and 586.2 ± 47.6, and 32.5 ± 6.8 lg/ml, respectively Table 1. There was no significant difference between methanolic and aqueous extracts of Eucalyptus. However, with increasing concentrations of methanolic and aqueous extracts of Eucalyptus or potassium antimonyl tartrate, optical density significantly decreased and inhibitory percentage increased, and the different concentrations resulted in different optical densities or inhibitory percentages (P \ 0.05).
Discussion
At present, there is no effective treatment for various forms of leishmaniasis. First choice treatment agents, antimony compounds are unsatisfactory due to their toxic effects, long duration of therapy and development of resistance (Hadighi et al. 2007 ). The choice of second-line drugs is very limited. Herbal medicines are rich sources of antileishmanial drugs with a shorter treatment cycles, orally administrable, safe, cheaper and fairly accessible in endemic countries (Monzote Fidalgo et al. 2004; Sereno et al. 2001; Shubhankar et al. 2011; Verma and Singh 2008) . Therefore, the need for the use of new medicinal plants is of prime importance.
In this study the anti-leishmanial effect of methanolic and aqueous extracts of Eucalyptus on L. major was evaluated on in vitro model.
One of the most important compounds extracted from Eucalyptus is 1,8-cineole, mainly due to its antibacterial and expectorant properties (Leung and Foster 1996) and also due to Hyprozoid and Coerstin has considerable antimicrobial, antiviral and antiprotozoan effect (Newall et al. 1996; Pattnaik et al. 1996) . Trivalent antimony form (SbIII) was used as positive control drug because of the appropriate effect on intracellular and extracellular forms of L. major (Sereno et al. 1998 ). Tartar emetic is 10-fold more effective and toxic to Leishmania species than meglumine antimoniate (Glucantime) or sodium stibogluconate (Pentostam), the main reason for the use of this drug as control.
In conclusion, the methanolic and aqueous extracts of E. camaldulensis extract showed a moderate leishmanicidal activity. Further investigations are needed to isolate and identify the active components. Aqueous extract 1,108.6 ± 51.9 Tartar emetic 32.5 ± 6.8
